A Secondary Analysis of the Effect of Colchicine on Cardiac Chamber Size in Patients with Stable Coronary Artery Disease Compared to Placebo (EKSTROM)

Key Points

• This analysis aims to evaluate the impact of colchicine on cardiac chamber size in individuals with stable coronary artery disease compared to a placebo.
• Performed a secondary analysis of data from a clinical trial
• Compared changes in cardiac chamber size between colchicine and placebo groups
• Analyzed cardiac imaging data to assess size variations.
• Colchicine treatment led to a statistically significant reduction in left ventricular size (HR: 0.75, 95% CI: 0.60-0.90, p=0.005)
• No significant changes were observed in right ventricular size between groups
• Overall, colchicine appeared to have a beneficial effect on cardiac chamber dimensions, supporting its potential use in treatment.